Paul Hastings

(Mr. Paul Hastings)

Currently holds positions in Protara Therapeutics Inc and Pacira Biosciences Inc

Positions

Position Company Period
Director Protara Therapeutics Inc Jan. 1, 2017 -
Lead Independent Director Pacira Biosciences Inc June 1, 2013 -
Chairman of the Board, Chief Executive Officer OncoMed Pharmaceuticals Inc Sept. 18, 2017 - Jan. 1, 2018
Chairman of the Board, President, Chief Executive Officer OncoMed Pharmaceuticals Inc Jan. 1, 2014 - Sept. 18, 2017
Chairman of the Board Protara Therapeutics Inc Oct. 18, 2016 - Jan. 1, 2017
President, Chief Executive Officer and Board Member OncoMed Pharmaceuticals Inc None -
Independent Director Pacira Biosciences Inc June 2, 2011 - June 1, 2013
Paul Hastings's trades of Nkarta Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-17 2025-01-15
US Nkarta Inc (NKTX)
S Sale
17,378 -5.2%
2.20
USD 38,232 		17,378 -5.2% 2.20 USD 38,232
2024-06-20 2024-06-18
US Nkarta Inc (NKTX)
S Sale
1,770 -0.7%
5.60
USD 9,912 		1,770 -0.7% 5.60 USD 9,912
2024-06-13 2024-06-13
PS Planned sale
880 -6.5%
28.38
USD 24,974 		880 -6.5% 28.38 USD 24,974
2024-01-18 2024-01-16
US Nkarta Inc (NKTX)
S Sale
9,697 -2.4%
8.74
USD 84,752 		9,697 -2.4% 8.74 USD 84,752
2023-06-22 2023-06-20
US Nkarta Inc (NKTX)
PS Planned sale
1,704 -0.5%
4.85
USD 8,264 		1,704 -0.5% 4.85 USD 8,264
2023-06-07 2023-06-05
S Sale
580 -8.1%
38.34
USD 22,237 		580 -8.1% 38.34 USD 22,237
2023-05-17 2023-05-15
PS Planned sale
7,000 -49.4%
41.85
USD 292,950 		7,000 -49.4% 41.85 USD 292,950
2023-01-18 2023-01-17
US Nkarta Inc (NKTX)
PS Planned sale
3,691 -1.2%
5.49
USD 20,264 		3,691 -1.2% 5.49 USD 20,264
2022-09-22 2022-09-21
US Nkarta Inc (NKTX)
PS Planned sale
6,126 -2.2%
13.01
USD 79,717 		6,126 -2.2% 13.01 USD 79,717
2022-07-13 2022-07-11
PS Planned sale
533 -6.9%
56.95
USD 30,354 		533 -6.9% 56.95 USD 30,354
2021-10-01 2021-09-29
US Nkarta Inc (NKTX)
PS Planned sale
223 -0.1%
26.53
USD 5,916 		223 -0.1% 26.53 USD 5,916
2021-10-01 2021-09-29
US Nkarta Inc (NKTX)
PS Planned sale
8,277 -3.6%
27.20
USD 225,134 		8,277 -3.6% 27.20 USD 225,134
2021-06-23 2021-06-21
US Nkarta Inc (NKTX)
PS Planned sale
3,807 -1.6%
26.89
USD 102,370 		3,807 -1.6% 26.89 USD 102,370
2021-06-23 2021-06-21
US Nkarta Inc (NKTX)
PS Planned sale
4,693 -2.0%
26.39
USD 123,848 		4,693 -2.0% 26.39 USD 123,848
2021-06-08 2021-06-04
PS Planned sale
630 -10.3%
62.19
USD 39,180 		630 -10.3% 62.19 USD 39,180
2021-04-01 2021-03-30
US Nkarta Inc (NKTX)
PS Planned sale
3,130 -1.3%
32.21
USD 100,817 		3,130 -1.3% 32.21 USD 100,817
2021-04-01 2021-03-30
US Nkarta Inc (NKTX)
PS Planned sale
2,409 -1.0%
31.24
USD 75,257 		2,409 -1.0% 31.24 USD 75,257
2021-04-01 2021-03-30
US Nkarta Inc (NKTX)
PS Planned sale
11,461 -4.5%
30.23
USD 346,466 		11,461 -4.5% 30.23 USD 346,466
2021-03-09 2021-03-05
S Sale
3,000 -32.9%
65.88
USD 197,640 		3,000 -32.9% 65.88 USD 197,640
2020-06-08 2020-06-04
S Sale
2,025 -29.4%
47.46
USD 96,107 		2,025 -29.4% 47.46 USD 96,107
2019-06-06 2019-06-04
PS Planned sale
782 -22.2%
42.66
USD 33,360 		782 -22.2% 42.66 USD 33,360
2017-10-12 2017-10-10
S Sale
52 -0.1%
4.26
USD 222 		52 -0.1% 4.26 USD 222
2016-06-08 2016-06-06
PS Planned sale
1,136 -39.8%
46.95
USD 53,335 		1,136 -39.8% 46.95 USD 53,335
2016-01-08 2016-01-06
PS Planned sale
2,335 -9.6%
22.30
USD 52,072 		2,335 -9.6% 22.30 USD 52,072
// ... existing code ... // ... rest of the file ...